KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Current Assets (2016 - 2025)

Charles River Laboratories International has reported Current Assets over the past 17 years, most recently at $1.4 billion for Q4 2025.

  • Quarterly results put Current Assets at $1.4 billion for Q4 2025, up 3.13% from a year ago — trailing twelve months through Dec 2025 was $1.4 billion (up 3.13% YoY), and the annual figure for FY2025 was $1.4 billion, up 3.13%.
  • Current Assets for Q4 2025 was $1.4 billion at Charles River Laboratories International, down from $1.5 billion in the prior quarter.
  • Over the last five years, Current Assets for CRL hit a ceiling of $1.7 billion in Q1 2024 and a floor of $1.3 billion in Q2 2021.
  • Median Current Assets over the past 5 years was $1.4 billion (2023), compared with a mean of $1.4 billion.
  • Biggest five-year swings in Current Assets: increased 17.79% in 2021 and later fell 12.78% in 2024.
  • Charles River Laboratories International's Current Assets stood at $1.3 billion in 2021, then grew by 12.95% to $1.4 billion in 2022, then rose by 11.79% to $1.6 billion in 2023, then decreased by 12.78% to $1.4 billion in 2024, then grew by 3.13% to $1.4 billion in 2025.
  • The last three reported values for Current Assets were $1.4 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.5 billion (Q2 2025) per Business Quant data.